Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)-AML206 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples